Astellas Pharma (Japan)

Profile subscribers click here for full profile

Astellas Pharma is one of Japan's leading pharmaceutical companies, now developing a growing international profile. Its top-selling drug in 2016 was the prostate cancer treatment Xtandi, backed by supporting products Eligard and Gonax. Other key medicines include Vesicare for over-active bladder and its successor Myrbetriq/Betmiga, and transplantation drug Prograf. It also owns lung cancer drug Tarceva, which is co-promoted by Roche/Genentech in Europe and the US. In its domestic market it has local rights to several well-known drugs including Pfizer's Lipitor, and AstraZeneca's Seroquel and Symbicort, and agreed a Japanese joint venture in 2013 with US biotech giant Amgen. Astellas Pharma was created in 2005 from the merger of two existing Japanese drug companies, Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical. Global revenues for year ending 2017 were approximately $12.1bn, incuding around $2.3bn from Xtandi, $1.7bn from Prograf and $1.1bn from Vesicare. Pfizer is now Astellas' co-promotion partner for Xtandi in the US (following its acquisition of original partner and co-developer Medivation). Japan accounted for a little over a third of group revenues, but sales from the Americas and EMEA have doubled in five years and now represent more than half the total. Yoshihiko Hatanaka is CEO. Adbrands does not currently profile this company but subscribers may access account assignments and contact information. The searchable account assignments database is available to full subscribers to premium services. Click here to access Adbrands account assignments (subscribers only); or see here for information on how to subscribe.

Which agencies handle advertising for Astellas? Find out more from the Adbrands Account Assignments database

Who are the competitors of Astellas? See Pharmaceutical Sector for other companies

Capsule checked 8th September 2016

Adbrands Company Profiles assess more than 1,000 leading advertisers, brands and agencies, and examine each company's business record, geographic strength and comparative performance within its chosen sector, including strengths and weaknesses, history, up-to-date news and top-line financial information. What else does the company do? How did it originate? What other brands does it own? How is it performing in the market? With what other businesses is it affiliated? 

Adbrands Account Assignments is a database tracking account management for the world's leading brands and companies. In other words, which advertising agency handles which accounts in which countries. Fully searchable by brand, brandowner company or advertising agency, the database now contains more than 15,000 worldwide account assignments for over 4,000 leading brands.

More about Company Profiles | More about Account Assignments

New to the industry? See here for a brief summary of how the agency business is structured.

Subscribe to to access the full profile and account assignments

All rights reserved © Mind Advertising Ltd 1998-2018